The US Food and Drug Administration (FDA) has approved Neurelis’ diazepam nasal spray, Valtoco, for the short-term treatment of acute repetitive seizures, also referred to as seizure clusters ...

The FDA approved Pfizer's newest drug on the migraine market, Zavzpret (zavegepant), the first and only migraine treatment offered in a nasal spray.

The FDA has approved Archimedes Pharma’s Lazanda nasal spray for the management of breakthrough pain in adult cancer patients, according to a report by the FDA. Breakthrough pain in cancer is an ...

This expanded approval makes Sonu the first FDA-approved, drug-free solution for nasal congestion due to allergic and nonallergic rhinitis in children ages ≥12 years.